CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 158 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,112,976 | -76.5% | 107,053 | -85.8% | 0.05% | -78.8% |
| Q1 2023 | $17,486,028 | -13.6% | 755,336 | -2.2% | 0.24% | -18.9% |
| Q4 2022 | $20,244,740 | +16.8% | 772,700 | -12.4% | 0.30% | +15.3% |
| Q3 2022 | $17,334,000 | +101.3% | 881,684 | +79.1% | 0.26% | +88.5% |
| Q2 2022 | $8,610,000 | – | 492,303 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |